Two key aspects from the CDC’s web page will directly affect all healthcare facilities relative to Emergency Operation Plans (EOP) and the ability to effectively respond to the spread of COVID-19. Preparing for a potential surge in patients with respiratory infection, regardless of COVID-19 infection status Preparing for potential personal protective equipment supply and staff…
In response to the threat posed by the spread of COVID-19, CMS has called for a suspension of most state agency and accrediting organization survey activities for the indefinite future. HFAP surveys that WILL go forward include: Incoming immediate jeopardy complaints alleging infection control breaches or abuse and neglect. Complaint Surveys (lower level than immediate…
Please share this announcement with: Medical Director, Laboratory Services Administrative Director and Managers, Laboratory Services Please note the CDC’s COVID-19 Information for Laboratories web page was updated on March 2, 2020. This revision includes an update to the Laboratory Biosafety Frequently Asked Questions (FAQs) to clarify practices for working inside a BSC and additional FAQs.…
Please share this announcement with: Medical Director, Laboratory Services Administrative Director and Managers, Laboratory Services The Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for the CDC 2019-Novel Coronavirus (COVID-19) Real-Time RT-PCR Diagnostic Panel which is to be used in qualified laboratories for testing patient respiratory specimens that meet CDC criteria for…
